54 participants
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-31
- Start Date:
- 2024-11-04
- Completion:
- 2029-11-01
Conditions
- Colorectal Cancer
- Pancreatic Cancer
Interventions
- DRUG
No Results Yet